Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Nephrol. Sep 25, 2025; 14(3): 108099
Published online Sep 25, 2025. doi: 10.5527/wjn.v14.i3.108099
Published online Sep 25, 2025. doi: 10.5527/wjn.v14.i3.108099
Unmasking the silent epidemic: Mortality trends in diabetic nephropathy
Mauricio Alvarez, Department of Endocrinology, Hospital Militar Central, Bogota 110221, Distrito Capital de Bogotá, Colombia
Author contributions: Alvarez M has completed the entire manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Mauricio Alvarez, MD, Department of Endocrinology, Hospital Militar Central, Tv. 3C No. 49-02, Bogota 110221, Distrito Capital de Bogotá, Colombia.
Received: April 7, 2025
Revised: April 23, 2025
Accepted: May 18, 2025
Published online: September 25, 2025
Processing time: 165 Days and 19.7 Hours
Revised: April 23, 2025
Accepted: May 18, 2025
Published online: September 25, 2025
Processing time: 165 Days and 19.7 Hours
Core Tip
Core Tip: The rising incidence of diabetes and its complications, including diabetic nephropathy, underscores the urgent need for comprehensive strategies. While new pharmacological treatments offer benefits, prioritizing public health policies focused on prevention and multidisciplinary care is crucial to effectively reduce the progression of chronic kidney disease and its associated mortality.